Applied DNA Sciences, Inc. (BNBX) - Total Liabilities
Based on the latest financial reports, Applied DNA Sciences, Inc. (BNBX) has total liabilities worth $1.50 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Applied DNA Sciences, Inc. - Total Liabilities Trend (2021–2025)
This chart illustrates how Applied DNA Sciences, Inc.'s total liabilities have evolved over time, based on quarterly financial data. See how liquid is Applied DNA Sciences, Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Applied DNA Sciences, Inc. Competitors by Total Liabilities
The table below lists competitors of Applied DNA Sciences, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oblong Inc
NASDAQ:OBLG
|
USA | $1.07 Million |
|
B90 HOLDINGS PLC
F:24GN
|
Germany | €1.56 Million |
|
Future PLC
LSE:FUTR
|
UK | GBX623.30 Million |
|
Stellar AfricaGold Inc.
V:SPX
|
Canada | CA$196.68K |
|
Willings Co. Ltd
KQ:313760
|
Korea | ₩31.30 Billion |
|
Xiwang Property Holdings Company Limited
F:XSA
|
Germany | €131.35 Million |
|
Knosys Ltd
AU:KNO
|
Australia | AU$7.55 Million |
|
CPU Softwarehouse AG
F:CPU2
|
Germany | €741.23K |
Liability Composition Analysis (2021–2025)
This chart breaks down Applied DNA Sciences, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Applied DNA Sciences, Inc..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Applied DNA Sciences, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Applied DNA Sciences, Inc. (2021–2025)
The table below shows the annual total liabilities of Applied DNA Sciences, Inc. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $2.50 Million | -34.68% |
| 2024-09-30 | $3.82 Million | -56.48% |
| 2023-09-30 | $8.78 Million | -6.17% |
| 2022-09-30 | $9.36 Million | +183.19% |
| 2021-09-30 | $3.30 Million | -- |
About Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more